review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Javier Gómez-Ambrosi | Q38319166 |
Gema Frühbeck | Q62991304 | ||
P2093 | author name string | Victoria Catalán | |
Amaia Rodríguez | |||
P2860 | cites work | Mechanisms linking excess adiposity and carcinogenesis promotion | Q27022929 |
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes | Q28590335 | ||
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome | Q29619211 | ||
Health Effects of Overweight and Obesity in 195 Countries over 25 Years | Q30402965 | ||
Rationale for the existence of additional adipostatic hormones. | Q34353837 | ||
Management of obesity | Q34513665 | ||
Effect of chronic and intermittent calorie restriction on serum adiponectin and leptin and mammary tumorigenesis | Q34765350 | ||
The Associations of Novel Vitamin D3 Metabolic Gene CYP27A1 Polymorphism, Adiponectin/Leptin Ratio, and Metabolic Syndrome in Middle-Aged Taiwanese Males | Q34987757 | ||
Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women. | Q35034838 | ||
Adiponectin and leptin concentrations may aid in discriminating disease forms in children and adolescents with type 1 and type 2 diabetes | Q80384709 | ||
Intracellular signalling pathways activated by leptin | Q36334963 | ||
Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio | Q36711762 | ||
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk. | Q36895502 | ||
Leptin and cardiovascular disease: response to therapeutic interventions | Q37198354 | ||
Targeting the adiponectin:leptin ratio for postmenopausal breast cancer prevention | Q37502198 | ||
Effects of dietary restriction on adipose mass and biomarkers of healthy aging in human. | Q37610197 | ||
Mechanisms of adiponectin regulation and use as a pharmacological target | Q37784586 | ||
Effect of diet on adiponectin levels in blood | Q37941771 | ||
Selective insulin and leptin resistance in metabolic disorders | Q38033748 | ||
Peripheral signalling involved in energy homeostasis control | Q38061797 | ||
Regulation of adipocyte lipolysis | Q38215702 | ||
From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century | Q38286539 | ||
Drug targeting of leptin resistance. | Q38298337 | ||
Exercise and Regulation of Adipokine and Myokine Production | Q38610406 | ||
A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk | Q38652676 | ||
Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies | Q41033539 | ||
Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome | Q41141093 | ||
Normalization of adiponectin concentrations by leptin replacement in ob/ob mice is accompanied by reductions in systemic oxidative stress and inflammation | Q42220499 | ||
Adiponectin-leptin ratio: a useful estimate of insulin resistance in patients with Type 2 diabetes | Q43168144 | ||
Adiponectin/leptin ratio and insulin resistance in pregnancy | Q44416921 | ||
Correlation between the adiponectin-leptin ratio and parameters of insulin resistance in patients with type 2 diabetes | Q45286377 | ||
Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe | Q47145734 | ||
Characterising metabolically healthy obesity in weight-discordant monozygotic twins | Q47206616 | ||
The effect of weight loss magnitude on pro-/anti-inflammatory adipokines and carotid intima-media thickness in obese adolescents engaged in interdisciplinary weight loss therapy. | Q47296927 | ||
A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays. | Q47440332 | ||
Atorvastatin and pitavastatin reduce oxidative stress and improve IR/LDL-R signals in Alzheimer's disease | Q48201019 | ||
The ominous triad of adipose tissue dysfunction: inflammation, fibrosis, and impaired angiogenesis | Q49430910 | ||
Obesity Pathogenesis: An Endocrine Society Scientific Statement | Q50130740 | ||
Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. | Q50466230 | ||
Relationship between the adiponectin-leptin ratio and parameters of insulin resistance in subjects without hyperglycemia. | Q51491843 | ||
The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes. | Q51584134 | ||
Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. | Q51814866 | ||
The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents. | Q53531979 | ||
Validity of adiponectin-to-leptin and adiponectin-to-resistin ratios as predictors of polycystic ovary syndrome. | Q53662878 | ||
Fitness, adiposopathy, and adiposity are independent predictors of insulin sensitivity in middle-aged men without diabetes. | Q53787695 | ||
Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity | Q57318459 | ||
The role of free fatty acids in the inflammatory and cardiometabolic profile in adolescents with metabolic syndrome engaged in interdisciplinary therapy | Q57588521 | ||
Comparison between body mass index and a body shape index with adiponectin/leptin ratio and markers of glucose metabolism among adolescents | Q58249205 | ||
Plasma Osteopontin Levels and Expression in Adipose Tissue Are Increased in Obesity | Q58283899 | ||
Increased cardiovascular risk markers in obesity are associated with body adiposity: Role of leptin | Q58283932 | ||
P921 | main subject | obesity | Q12174 |
P304 | page(s) | 1-6 | |
P577 | publication date | 2017-12-05 | |
P1433 | published in | Adipocyte | Q26853830 |
P1476 | title | Adiponectin-leptin ratio: A promising index to estimate adipose tissue dysfunction. Relation with obesity-associated cardiometabolic risk |
Q64114247 | Adiponectin-leptin Ratio is a Functional Biomarker of Adipose Tissue Inflammation |
Q64968430 | An Interdisciplinary Weight Loss Program Improves Body Composition and Metabolic Profile in Adolescents With Obesity: Associations With the Dietary Inflammatory Index. |
Q57298171 | Effect of personalized moderate exercise training on Wistar rats fed with a fructose enriched water |
Q100395039 | Effects of an early life diet containing large phospholipid-coated lipid globules on hepatic lipid metabolism in mice |
Q93102769 | Increase of the Adiponectin/Leptin Ratio in Patients with Obesity and Type 2 Diabetes after Roux-en-Y Gastric Bypass |
Q99570591 | Obese Adipose Tissue Secretion Induces Inflammation in Preadipocytes: Role of Toll-Like Receptor-4 |
Q89717656 | Ovine prenatal growth-restriction and sex influence fetal adipose tissue phenotype and impact postnatal lipid metabolism and adiposity in vivo from birth until adulthood |
Q64073187 | Psoriasis in obesity: comparison of serum levels of leptin and adiponectin in obese subjects - cases and controls |
Q92503705 | Serum Adipokines, Growth Factors, and Cytokines Are Independently Associated with Stunting in Bangladeshi Children |
Q89577655 | Serum leptin, resistin, and adiponectin levels in obese and non-obese patients with newly diagnosed type 2 diabetes mellitus: A population-based study |
Q90575050 | The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts |
Q90230245 | The cholecystokinin receptor agonist, CCK-8, induces adiponectin production in rat white adipose tissue |
Q100416051 | The leptin to adiponectin ratio (LAR) is reduced by sleeve gastrectomy in adults with severe obesity: a prospective cohort study |
Q91782097 | Towards precision medicine: defining and characterizing adipose tissue dysfunction to identify early immunometabolic risk in symptom-free adults from the GEMM family study |
Search more.